Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Core Scientific (CORZZ) Equity Average (2021 - 2025)

Historic Equity Average for Core Scientific (CORZZ) over the last 5 years, with Q3 2025 value amounting to -$1.1 billion.

  • Core Scientific's Equity Average fell 1985.55% to -$1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 billion, marking a year-over-year decrease of 1985.55%. This contributed to the annual value of -$708.6 million for FY2024, which is 4082.67% down from last year.
  • Core Scientific's Equity Average amounted to -$1.1 billion in Q3 2025, which was down 1985.55% from -$623.1 million recorded in Q2 2025.
  • Core Scientific's Equity Average's 5-year high stood at $1.2 billion during Q1 2022, with a 5-year trough of -$1.1 billion in Q3 2025.
  • Over the past 5 years, Core Scientific's median Equity Average value was -$403.4 million (recorded in 2023), while the average stood at -$211.5 million.
  • Per our database at Business Quant, Core Scientific's Equity Average skyrocketed by 933141.63% in 2022 and then tumbled by 26572.05% in 2023.
  • Core Scientific's Equity Average (Quarter) stood at $645.1 million in 2021, then crashed by 126.07% to -$168.2 million in 2022, then plummeted by 202.0% to -$507.8 million in 2023, then crashed by 52.57% to -$774.8 million in 2024, then tumbled by 41.5% to -$1.1 billion in 2025.
  • Its last three reported values are -$1.1 billion in Q3 2025, -$623.1 million for Q2 2025, and -$500.8 million during Q1 2025.